Postmenopausal Osteoporosis Treatments

Find Postmenopausal Osteoporosis Treatments

Generic Name

Alendronate

Brand Names
Binosto, Fosamax
FDA approval date: February 06, 2008
Classification: Bisphosphonate
Form: Tablet, Solution

What is Binosto (Alendronate)?

BINOSTO is a bisphosphonate indicated for: Treatment of osteoporosis in postmenopausal women.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

Small Trial of Alendronate Impact on the Reservoir of HIV

Summary: This clinical trial is designed to test the effects of alendronate (ALN) on people living with HIV who are already receiving antiretroviral therapy (ART). Participants are randomly assigned in a 2:1 ratio to either receive alendronate or a placebo, and neither the participants nor the researchers know who is receiving the actual treatment. The goal is to see if alendronate can reduce the size and ...

The Effect of Oral Administration of Alendronate on Knee Functions Following Anterior Cruciate Ligament Reconstruction - A Multi-Centre, Double-Blind, Placebo-Controlled, Randomized Trial

Summary: Anterior cruciate ligament (ACL) is the key ligament connecting the femur to tibia that helps stabilising the knee joint. ACL tear is common. It accounts for over 50% of all knee injuries and affects more than 200,000 people in the United States each year. Patients with ACL tear have a higher risk of developing post-traumatic osteoarthritis. ACL reconstruction (ACLR) with the attachment of tendon ...

A Feasibility Study of Alendronate as Treatment for Osteonecrosis in Adults With Sickle Cell Disease

Summary: A prospective, single-arm, intervention study of oral alendronate in adults with sickle cell disease and osteonecrosis

Brand Information